Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-24 @ 9:22 PM
NCT ID:
NCT07057804
Eligibility Criteria:
Inclusion Criteria:
* All patients who will meet the following weaning criteria undergo Spontaneous Breathing Trial, which include,
* Improvement of disease acute phase which necessitated mechanical ventilation.
* Stable neurological status.
* No hemodynamic instability (heart rate ≤ 120/min, systolic blood pressure higher than 90 mmHg and lower than 160 mmHg) in the absence of any vasoactive support therapy.
* PaO2\>60 mm Hg or SaO2 ≥ 90% or more with FiO2 ≤ 0.4.
* Afebrile and there were no significant abnormalities in the electrolyte levels.
Exclusion Criteria:
* Hemodynamic unstable patients
* Patients with severe intracranial disease,
* Tracheostomy.
* Severe intensive care unit (ICU) acquired neuromyopathy, with primary unilateral/bilateral absence of diaphragmatic mobility,
* Patients who had previously failed spontaneous breathing trial (SBT).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07057804
Study Brief:
Protocol Section:
NCT07057804